• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Device Problems Calcified (1077); Material Perforation (2205)
Patient Problem Aortic Valve Stenosis (1717)
Event Type  Injury  
Event Description
On (b)(6) 2016, a 23mm trifecta valve was implanted in the aortic position.Severe aortic stenosis was confirmed, so on (b)(6) 2019, the device was explanted and observed to be calcified.The device was replaced with a 23mm edwards intuity valve.The patient is reported to be stable.It was noted that the patient had chronic renal insufficiency requiring dialysis.
 
Event Description
(b)(6) 2016, a 23mm trifecta valve was implanted in the aortic position.Severe aortic stenosis was confirmed, so on (b)(6) 2019, the device was explanted and observed to be calcified, immobile, and a cusp was perforated.The device was replaced with a 23mm edwards intuity valve.The patient is reported to be stable.It was noted that the patient had chronic renal insufficiency requiring dialysis.
 
Manufacturer Narrative
The valve was explanted due to stenosis.The calcification noted at explant was confirmed.All three leaflets were fibrotically thickened and contained calcifications which immobilized the leaflets and created incomplete coaptation.Fibrous pannus ingrowth was found on the inflow surface of leaflets 1 and 2.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.The root cause of the calcification could not be conclusively determined.Calcification is a known event associated with tissue heart valves.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS  1897-4050
MDR Report Key8488201
MDR Text Key141082348
Report Number3008452825-2019-00148
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public05414734052030
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 07/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/06/2018
Device Model NumberTF-23A
Device Lot Number5441997
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/11/2018
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/13/2019
Initial Date FDA Received04/05/2019
Supplement Dates Manufacturer Received05/06/2019
06/17/2019
Supplement Dates FDA Received05/30/2019
07/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-